hCFB

品系全名

C57BL/6JSmo-Cfbtm1(hCFB)Smoc

目录号

NM-HU-2000078

品系状态

活体

导出PDF

基因信息

基因名
Cfb

品系描述

通过同源重组,将小鼠Cfb基因进行人源化修饰。
应用领域:免疫治疗;药物筛选

验证数据

image.png

Fig1. Detection of CFB expression in liver by RT-PCR. 

Wild type: only one band at 441 bp with primers F1/R1(mCfb);

Homozygous: only one band at 442 bp with primers F2/R2(hCFB); 

Abbr. M, DNA marker; HO, homozygous; WT, wild type.

image.png

Fig2. Detection of human and mouse CFB expression in serum by ELISA (n=2). 

Abbr. HO, homozygous; WT, wild type.

Note: The mouse CFB ELISA kit cross-reacted with mCFB and humanized CFB.

image.png

Fig3. Detection of hCFB expression in serum by ELISA(n=3/group). 

Abbr. HO, homozygous; WT, wild type

image.png

Fig4. Body Weight(A) and Survival Curve(B) of WT C57BL/6 and HO hCFB mice.

Abbr. HO, homozygous; WT, wild type.

image.png

Fig5. Blood Biochemistry of WT C57BL/6 and HO hCFB mice.

Abbr. HO, homozygous; WT, wild type.

image.png

Fig6. Detection of liver CFB mRNA remaining at Day 7 (A) and serum protein level (B) after single dose of test drug (n=3/group). (Data from a collaborator)

image.png

Fig7.Partial representative pictures of liver and kidney pathology in hCFB knockin mice. No obvious lesions were observed in hCFB knockin mice. 


你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

查看

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看